Vifor Pharma (United States)

Recent papers from Vifor Pharma (United States)

1. Phase 1 safety, tolerability, and pharmacokinetics of NS-863 supporting development for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung diseaseEuropean Heart Journal · 2026
2. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trialThe Lancet · 2019
3. Sparsentan - SGLT2 inhibitor combination therapy in trials of IgA nephropathyNephrology Dialysis Transplantation · 2026
4. Real-world all-cause healthcare resource utilization and costs among patients with interstitial cystitis/bladder pain syndrome in the United StatesJournal of Medical Economics · 2026
5. Spatial transcriptomics reveal heterogeneous cell‒cell interactions among brain regions in cuprizone model consistent with multiple sclerosis lesionsFrontiers in Bioinformatics · 2026
6. Cubosomes in Anticancer Drug Delivery: Structural Insights, Formulation Strategies, and Translational PerspectivesChemistrySelect · 2026
7. Uric acid is closely linked to vascular nitric oxide activityJournal of the American College of Cardiology · 2001
8. Fecal gas time curve analysis for health monitoringJournal of Breath Research · 2026
9. Dose-Expansion Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid TumorsThe Oncologist · 2026
10. A study of MT-4561 in patients with various advanced solid tumors (NCT06943521).Journal of Clinical Oncology · 2026
11. Distilling Clinical Reasoning from Text Corpora for Explainable AI in Medical ImagingIEEE Journal of Biomedical and Health Informatics · 2026
12. Enhancing the therapeutic efficacy of curcumin in topical applications through nanoformulationsNatural Product Research · 2026
13. Treatment with low-dose bicistronic immunotherapy mitigates parasite persistence and improves serological and cardiac outcomes in adult mice infected with Trypanosoma cruzi : comparative analysis with benznidazoleEmerging Microbes & Infections · 2026
14. Abstract 3062: TRIM7 inhibition blocks RTK/RAS pathway driven tumor proliferation independent of mutation and in the setting of KRASi resistanceCancer Research · 2026
15. Abstract 1756: Novel HER2 antibody drug conjugates with stable hydrophilic linkersCancer Research · 2026
16. Structural and In silico safety evaluation of asciminib degradation products with a validated stability indicating HPLC method for genotoxic impurity determinationScientific Reports · 2026
17. Nutrient gaps are prevalent among women experiencing infertility, a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES), 2013–2020PLoS ONE · 2026
18. Introduction to the SupplementMuscle & Nerve · 2026
19. Safety of Intravenous Edaravone in Clinical PracticeMuscle & Nerve · 2026
20. Generalizability of Edaravone Efficacy.2026